Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Gardasil 9 in the treatment of difficult-to-treat palmo-plantar warts
2021-000333-13Phase 3Active
- Sponsor
- Direction de la Recherche Clinique et de l'Innovation
- Start
- Aug 2021
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in verruca comparing Gardasil 9 with Placebo (2 arms). Primary endpoint: Complete remission of cutaneous warts. Started Aug 2021; status: active.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
verruca
Beyond the preview
Go deeper on 2021-000333-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000333-13.